1. Home
  2. UVSP vs CSTL Comparison

UVSP vs CSTL Comparison

Compare UVSP & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Univest Financial Corporation

UVSP

Univest Financial Corporation

HOLD

Current Price

$37.83

Market Cap

983.8M

Sector

Finance

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$25.31

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVSP
CSTL
Founded
1876
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
983.8M
806.3M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
UVSP
CSTL
Price
$37.83
$25.31
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$36.67
$45.50
AVG Volume (30 Days)
185.3K
257.1K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
2.45%
N/A
EPS Growth
21.32
N/A
EPS
3.13
N/A
Revenue
$328,056,000.00
$344,229,000.00
Revenue This Year
$11.65
$2.42
Revenue Next Year
$4.77
$12.69
P/E Ratio
$12.00
N/A
Revenue Growth
9.64
3.66
52 Week Low
$27.91
$14.59
52 Week High
$38.71
$44.28

Technical Indicators

Market Signals
Indicator
UVSP
CSTL
Relative Strength Index (RSI) 68.07 47.98
Support Level $32.00 $21.77
Resistance Level N/A $26.44
Average True Range (ATR) 1.03 1.16
MACD 0.04 0.24
Stochastic Oscillator 78.07 63.39

Price Performance

Historical Comparison
UVSP
CSTL

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: